[ad_1] CAMBRIDGE, Mass.–(BUSINESS WIRE)– VBI Vaccines (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that results from the pivotal Phase 3 study, CONSTANT, of VBI’s prophylactic 3-antigen hepatitis B (HBV) vaccine candidate in adults age 18-45 were published in The Journal of
advice
[ad_1] Last year saw record sales in the UK for electric vehicles, with 59,945 EVs registered throughout the year. December saw EVs have a 3.8 percent split of the UK’s market share, with almost 5,500 electric vehicles registered in the last month of the year. This increase in popularity coincides with the upcoming Government ban